Christy L Shaffer
CIK 1145929 · President & CEO · last filed 2024-06-21
Christy L Shaffer is a President & CEO who has filed 35 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CLSD, was dated Jun 21, 2024. Across all open-market trades the lifetime net is +$149.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $372 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GRAY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4222 EMPEROR BLVD., STE. 470
DURHAM, NC 27703-8466
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 293 | $0.35 | $103 | $31.7K | 12 | 2024-06-21 |
| CALC | Director | 286 | $1.30 | $372 | $0 | 1 | 2023-03-27 |
| CalciMedica, Inc. (GRAY) Delisted | Director | 113,321 | $5.50 | $623.3K | $300.0K | 3 | 2022-06-03 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 995 | $7.15 | $7.1K | $0 | 3 | 2017-12-04 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | President & CEO | 357,297 | — | — | -$181.9K | 16 | 2009-12-08 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-27 | CALC | Disp (D) | +1,429 | $0 | EDGAR |
| 2022-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-29 | CalciMedica, Inc. (GRAY) Delisted | Mixed | +1,605,240 | $300.0K | EDGAR |
| 2020-06-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.